Compare STTK & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | SRTA |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | N/A | 601 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.3M | 530.4M |
| IPO Year | 2020 | N/A |
| Metric | STTK | SRTA |
|---|---|---|
| Price | $4.18 | $5.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $10.00 | $7.81 |
| AVG Volume (30 Days) | 860.8K | ★ 954.8K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,000,000.00 | N/A |
| Revenue This Year | N/A | $39.27 |
| Revenue Next Year | N/A | $8.52 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $3.85 |
| 52 Week High | $8.33 | $6.50 |
| Indicator | STTK | SRTA |
|---|---|---|
| Relative Strength Index (RSI) | 28.36 | 46.08 |
| Support Level | $3.67 | $5.16 |
| Resistance Level | $4.23 | $5.95 |
| Average True Range (ATR) | 0.51 | 0.28 |
| MACD | -0.15 | -0.12 |
| Stochastic Oscillator | 27.29 | 13.48 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.